Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents - PubMed

Review

Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents

U Naidoo et al. Psychoneuroendocrinology. 2003 Apr.

Abstract

The prevalence of schizophrenia is about 1% worldwide. Individuals with schizophrenia are at increased risk for osteoporosis and fractures for several reasons, including poor diet, lack of exercise, cigarette smoking, and polydipsia. Some antipsychotic medications may further increase the risk of fractures by causing dizziness, orthostatic hypotension, and falls. Studies in women with hyperprolactinemia resulting from pituitary tumors have demonstrated high rates of osteoporosis believed to result from hypoestrogenism. Similarly, hyperprolactinemia in men results in hypogonadism and bone loss. Preliminary surveys have indicated that schizophrenia patients also may have elevated rates of osteoporosis and pathological fractures, possibly resulting in part from the long-term administration of antipsychotic agents that produce hyperprolactinemia and secondarily lower estrogen and testosterone levels. This potential complication of treatment with certain antipsychotic agents requires careful study and could represent a serious public health problem.

Similar articles

• Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia.

  O'Keane V. O'Keane V. J Psychopharmacol. 2008 Mar;22(2 Suppl):70-5. doi: 10.1177/0269881107088439. J Psychopharmacol. 2008. PMID: 18477623 Review.

• Bone loss associated with hyperprolactinemia in patients with schizophrenia.

  Kinon BJ, Liu-Seifert H, Stauffer VL, Jacob J. Kinon BJ, et al. Clin Schizophr Relat Psychoses. 2013 Oct;7(3):115-23. doi: 10.3371/CSRP.KISE.020113. Clin Schizophr Relat Psychoses. 2013. PMID: 23395836 Clinical Trial.

• Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review.

  De Hert M, Detraux J, Stubbs B. De Hert M, et al. Expert Opin Drug Saf. 2016 Jun;15(6):809-23. doi: 10.1517/14740338.2016.1167873. Epub 2016 Apr 6. Expert Opin Drug Saf. 2016. PMID: 26986209 Review.

• Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia?

  O'Keane V, Meaney AM. O'Keane V, et al. J Clin Psychopharmacol. 2005 Feb;25(1):26-31. doi: 10.1097/01.jcp.0000150223.31007.e0. J Clin Psychopharmacol. 2005. PMID: 15643097

• [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].

  Besnard I, Auclair V, Callery G, Gabriel-Bordenave C, Roberge C. Besnard I, et al. Encephale. 2014 Feb;40(1):86-94. doi: 10.1016/j.encep.2012.03.002. Epub 2013 Aug 5. Encephale. 2014. PMID: 23928066 Review. French.

Cited by

• Risk of falls and fractures in older adults using antipsychotic agents: a propensity-matched retrospective cohort study.

  Mehta S, Chen H, Johnson ML, Aparasu RR. Mehta S, et al. Drugs Aging. 2010 Oct 1;27(10):815-29. doi: 10.2165/11537890-000000000-00000. Drugs Aging. 2010. PMID: 20883062

• The smoking patterns of women in their forties: their relationship to later osteoporosis.

  Brook JS, Balka EB, Zhang C. Brook JS, et al. Psychol Rep. 2012 Apr;110(2):351-62. doi: 10.2466/13.18.PR0.110.2.351-362. Psychol Rep. 2012. PMID: 22662390 Free PMC article.

• Sensors in Bone: Technologies, Applications, and Future Directions.

  Anwar A, Kaur T, Chaugule S, Yang YS, Mago A, Shim JH, John AA. Anwar A, et al. Sensors (Basel). 2024 Sep 24;24(19):6172. doi: 10.3390/s24196172. Sensors (Basel). 2024. PMID: 39409211 Free PMC article. Review.

• Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.

  DE Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, Detraux J, Gautam S, Möller HJ, Ndetei DM, Newcomer JW, Uwakwe R, Leucht S. DE Hert M, et al. World Psychiatry. 2011 Feb;10(1):52-77. doi: 10.1002/j.2051-5545.2011.tb00014.x. World Psychiatry. 2011. PMID: 21379357 Free PMC article.

• Pharmacological interventions for challenging behaviour in children with intellectual disabilities: a systematic review and meta-analysis.

  McQuire C, Hassiotis A, Harrison B, Pilling S. McQuire C, et al. BMC Psychiatry. 2015 Nov 26;15:303. doi: 10.1186/s12888-015-0688-2. BMC Psychiatry. 2015. PMID: 26611280 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Medical

  • MedlinePlus Health Information